A 8 week, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of IRT5 probiotics on atopic dermatitis in children

Korea Yakult Corporation0 个研究点目标入组 110 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•1)subject who signs ICF with a legal representative who signs the informed consent form before participating in the study
•2)subject aged between 5 years and 12 years with atopic dermatitis
•3)subject with intermittent or continuous atopic dermatits symptom over 6 months
•4)subject with SCORAD index between 25 and 50

•1)subject with other systemic illnesses or dermatits history except AD
•2)subject administrating immunosuppressant,antobiotics,corticosteroid, antihistaminic within 4 weeks
•3)subject who has taken medicines,chinese medicine, health functional foods within 4 weeks for improvement of atopic dermatitis
•4)subject with systemic phototherapy within 1 month
•5)subject with probiotics within 2 weeks
•6)subject who has taken scheduled for participating in another study during this study period or who had participated in other study within 4 weeks
•7)Inappropriate subject decided by investigator

发起方

Korea Yakult Corporation